India covid-19 testing India

AIIMS chief shares two important learnings from treatment of Covid-19

Reading now: 163
www.livemint.com

ANI.On the usage and efficacy of the anti-viral drug Remdesivir, Guleria raised a pertinent point. He highlighted, "It's important to understand that Remdesivir isn't magic bullet and isn't a drug that decreases mortality.

We may use it as we don't have an anti-viral drug. It's of no use if given early to asymptomatic individuals/ones with mild symptoms.

Also of no use, if given late."Moreover, he added that Remdesivir should only be given to patients who are hospitalised, have a fall in oxygen saturation and have infiltrates on the chest X-ray or CT-scan."Recovery trials showed that steroids will benefit but it's also important to know when they're given.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA